Company News

Lifespan introduces R.I.S.C. test A safe & non-invasive test for early detection & prevention of complication

risc-testLifespan, Indias largest chain of diabetes and cardiometabolic clinics, introduces the R.I.S.C. test – a unique, non-invasive, screening test for risk assessment by screening and understanding the risk to other organs due to diabetes.


Understanding R.I.S.C. test

The R.I.S.C. test is safe and non-invasive as no blood samples are taken, nothing introduced into the body and no harmful rays used. It also makes treatment cost-effective, as it identifies which organs are likely to be affected, so that treatment to prevention the complications can be started.

It is recommended for overweight and obese people, those with a family history of diabetes, high blood pressure and high cholesterol, pre-diabetics, etc., so that the diseases can be detected at an earlier stage and the measures to control the same can be initiated.


R.I.S.C. Test – Key Takeaways

  • Screens an individual for risk of developing diabetes by calculating insulin resistance.
  • Assesses ones cardio metabolic risk score and autonomic neuropathy risk score.
  • Tells about ones body fat composition, heart functioning and the functioning of the autonomic nervous system, and sudomotor nerves.
  • Assesses 30 vital health indicators that give an idea regarding ones risk of developing neuropathies and heart-related complications.

Additional Features

  • Identifies how diabetes is affecting your organs and what diabetic complications you may have developed and also are at risk of developing.
  • Detects cardio-metabolic-related problems, cardiac autonomic neuropathy, diabetic autonomic neuropathy, arterial stiffness and sudomotor abnormalities.
  • Analyses a persons present health status- the test checks for markers of underlying abnormal health condition by detecting small physiological changes.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top